February 1, 2025 - 07:03

Prospect Medical Holdings has announced its intention to sell the troubled Crozer Health system, located in Delaware County, to a consortium of not-for-profit organizations. While the specifics regarding the parties involved in this consortium have not been disclosed, the move is seen as a significant step toward stabilizing the healthcare provider, which has faced numerous challenges in recent years.
The decision to pursue a sale comes amid increasing scrutiny of the operations and financial health of Crozer Health. Stakeholders have expressed concerns about the quality of care and the sustainability of services offered within the system. By transitioning to a not-for-profit model, there is hope that the consortium will prioritize community health needs and improve the overall quality of care.
The potential sale is part of a broader trend in the healthcare industry, where not-for-profit organizations are increasingly stepping in to manage facilities that are struggling under for-profit ownership. As discussions progress, many in the community are eager to see how this change might positively impact healthcare access and services in the region.
July 23, 2026 - 15:06
Good riddance to bundled ‘global’ maternal care billingThe American College of Obstetricians and Gynecologists is welcoming a major shift in how pregnancy and childbirth are billed. For years, the system relied on a single, bundled `global` fee that...
July 22, 2026 - 21:50
West Nile virus found in two mosquito traps in DeKalb County, health officials sayHealth authorities in DeKalb County have confirmed that mosquitoes collected from two separate traps have tested positive for the West Nile virus. The positive samples were identified during...
July 22, 2026 - 08:37
Bradford A&E services downgraded by health watchdogA health watchdog has downgraded the accident and emergency services at Bradford Royal Infirmary following an inspection that uncovered significant concerns. The Care Quality Commission (CQC) found...
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...